Bridgeway Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History

Bridgeway Capital Management’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,553	Closed	-$37.2K	–	1444
2022 Q4	$37.2K	Sell	7,553 -360	-5%	-$2.98K	﹤0.01%	1319
2022 Q3	$89K	Hold	7,913	–	–	﹤0.01%	1295
2022 Q2	$108K	Hold	7,913	–	–	﹤0.01%	1213
2022 Q1	$410K	Buy	+7,913	New	+$350K	0.01%	990

Other funds holding MTEM

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bridgeway Capital Management's MTEM Position: Q1 2023 in Review

Bridgeway Capital Management sold out of Molecular Templates, Inc. (MTEM) in Q1 2023, closing a stake of 7,553 shares — an estimated $37.2K sold.

Bridgeway Capital Management first reported a position in MTEM in Q1 2022 and held it in 4 quarters. The position peaked at $410K in Q1 2022. 41 funds tracked by Wall St. Rank hold MTEM as of Q1 2023.

Bridgeway Capital Management reported no remaining Molecular Templates, Inc. position as of Q1 2023 after selling out during the quarter.
Bridgeway Capital Management sold 7,553 Molecular Templates, Inc. shares in Q1 2023, an estimated $37.2K.
Bridgeway Capital Management first reported a position in Molecular Templates, Inc. in Q1 2022 and held it in 4 quarters.
Bridgeway Capital Management's Molecular Templates, Inc. position peaked at $410K in Q1 2022.
41 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2023.

Based on Bridgeway Capital Management's 13F filing for Q1 2023, filed 15 May 2023.